{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:57:08Z","timestamp":1774681028367,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1074\/jbc.ra120.015327","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T16:45:11Z","timestamp":1609260311000},"page":"100241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["A conformation-specific antibody against oligomeric \u03b2-amyloid restores neuronal integrity in a mouse model of Alzheimer's disease"],"prefix":"10.1016","volume":"296","author":[{"given":"Ping","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7301-230X","authenticated-orcid":false,"given":"Michael R.","family":"Sierks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA120.015327_bib1","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1021\/cr3000994","article-title":"The amyloid beta peptide: A chemist's perspective. Role in Alzheimer's and fibrillization","volume":"112","author":"Hamley","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1074\/jbc.RA120.015327_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000369101","article-title":"Amyloid-beta: A crucial factor in Alzheimer's disease","volume":"24","author":"Sadigh-Eteghad","year":"2015","journal-title":"Med. Princ. Pract."},{"key":"10.1074\/jbc.RA120.015327_bib3","doi-asserted-by":"crossref","first-page":"20631","DOI":"10.1074\/jbc.271.34.20631","article-title":"Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease","volume":"271","author":"Roher","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.RA120.015327_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1074\/jbc.RA120.015327_bib5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"key":"10.1074\/jbc.RA120.015327_bib6","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.3390\/ijms13067303","article-title":"The toxicity of amyloid beta oligomers","volume":"13","author":"Zhao","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1074\/jbc.RA120.015327_bib7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0169-409X(02)00149-7","article-title":"Amyloidosis and Alzheimer's disease","volume":"54","author":"Ghiso","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1074\/jbc.RA120.015327_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0896-6273(01)00475-5","article-title":"Clearing the brain's amyloid cobwebs","volume":"32","author":"Selkoe","year":"2001","journal-title":"Neuron"},{"key":"10.1074\/jbc.RA120.015327_bib9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1074\/jbc.RA120.015327_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ana.22052","article-title":"Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers","volume":"68","author":"Gandy","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1074\/jbc.RA120.015327_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.abb.2010.02.001","article-title":"Size-dependent neurotoxicity of beta-amyloid oligomers","volume":"496","author":"Cizas","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1074\/jbc.RA120.015327_bib12","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M201750200","article-title":"Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability","volume":"277","author":"Dahlgren","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.RA120.015327_bib13","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","article-title":"In\u00a0vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis","volume":"278","author":"Stine","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.RA120.015327_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ab.2011.03.020","article-title":"Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach","volume":"414","author":"Bartolini","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1074\/jbc.RA120.015327_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nsmb.1799","article-title":"Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils","volume":"17","author":"Ahmed","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1074\/jbc.RA120.015327_bib16","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.neurobiolaging.2010.09.020","article-title":"Nanobody specific for oligomeric beta-amyloid stabilizes nontoxic form","volume":"33","author":"Kasturirangan","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.RA120.015327_bib17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jmb.2008.09.068","article-title":"Anti-oligomeric Abeta single-chain variable domain antibody blocks Abeta-induced toxicity against human neuroblastoma cells","volume":"384","author":"Zameer","year":"2008","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1074\/jbc.RA120.015327_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/btpr.1698","article-title":"Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples","volume":"29","author":"Kasturirangan","year":"2013","journal-title":"Biotechnol. Prog."},{"key":"10.1074\/jbc.RA120.015327_bib19","doi-asserted-by":"crossref","first-page":"11940","DOI":"10.1021\/acs.langmuir.9b01645","article-title":"Size-dependent interaction of amyloid beta oligomers with brain total lipid extract bilayer - fibrillation vs. membrane destruction","volume":"35","author":"Mrdenovic","year":"2019","journal-title":"Langmuir"},{"key":"10.1074\/jbc.RA120.015327_bib20","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A\u00a0beta oligomers - a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.RA120.015327_bib21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3233\/JAD-2011-111196","article-title":"Bispecific tandem single chain antibody simultaneously inhibits beta-secretase and promotes alpha-secretase processing of AbetaPP","volume":"28","author":"Boddapati","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.RA120.015327_bib22","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1007\/s12035-019-1597-z","article-title":"Bispecific antibody fragment targeting APP and inducing alpha-site cleavage restores neuronal health in an Alzheimer's mouse model","volume":"56","author":"He","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1074\/jbc.RA120.015327_bib23","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/mt.2014.129","article-title":"ESCRT-mediated uptake and degradation of brain-targeted alpha-synuclein single chain antibody attenuates neuronal degeneration in\u00a0vivo","volume":"22","author":"Spencer","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1074\/jbc.RA120.015327_bib24","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0702170104","article-title":"Targeted delivery of proteins across the blood-brain barrier","volume":"104","author":"Spencer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.RA120.015327_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ejn.13056","article-title":"Oligomeric alpha-synuclein and beta-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases","volume":"43","author":"Williams","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1074\/jbc.RA120.015327_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3233\/JAD-161116","article-title":"Blood-based oligomeric and other protein variant biomarkers to facilitate pre-symptomatic diagnosis and staging of Alzheimer's disease","volume":"58","author":"Williams","year":"2017","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.RA120.015327_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in\u00a0vivo: Evidence for augmentation of a 42-specific gamma secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1074\/jbc.RA120.015327_bib28","first-page":"51","article-title":"Assembly of \u03b2-amyloid aggregates at the molecular level","volume":"13","author":"Parker","year":"2000","journal-title":"Chemtracts"},{"key":"10.1074\/jbc.RA120.015327_bib29","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.embor.7400784","article-title":"Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology","volume":"7","author":"Radde","year":"2006","journal-title":"EMBO Rep."},{"key":"10.1074\/jbc.RA120.015327_bib30","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3727\/096368915X688894","article-title":"Human umbilical cord blood-derived monocytes improve cognitive deficits and reduce amyloid-beta pathology in PSAPP mice","volume":"24","author":"Darlington","year":"2015","journal-title":"Cell Transpl."},{"key":"10.1074\/jbc.RA120.015327_bib31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00401-012-1047-8","article-title":"Amyloid plaque formation precedes dendritic spine loss","volume":"124","author":"Bittner","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1074\/jbc.RA120.015327_bib32","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/mp.2013.122","article-title":"Chronic gamma-secretase inhibition reduces amyloid plaque-associated instability of pre- and postsynaptic structures","volume":"19","author":"Liebscher","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1074\/jbc.RA120.015327_bib33","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1093\/hmg\/ddu370","article-title":"Deficiency of patched 1-induced Gli1 signal transduction results in astrogenesis in Swedish mutated APP transgenic mice","volume":"23","author":"He","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1074\/jbc.RA120.015327_bib34","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1523\/JNEUROSCI.0421-09.2009","article-title":"Interruption of beta-catenin signaling reduces neurogenesis in Alzheimer's disease","volume":"29","author":"He","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1074\/jbc.RA120.015327_bib35","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1523\/JNEUROSCI.0395-10.2010","article-title":"Memory impairment in transgenic Alzheimer mice requires cellular prion protein","volume":"30","author":"Gimbel","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1074\/jbc.RA120.015327_bib36","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1021\/jacs.5b11913","article-title":"Amyloid beta-protein assembly and Alzheimer's disease: Dodecamers of Abeta42, but not of Abeta40, seed fibril formation","volume":"138","author":"Economou","year":"2016","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1074\/jbc.RA120.015327_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-neuro-071714-033828","article-title":"Neurodegenerative diseases: Expanding the prion concept","volume":"38","author":"Walker","year":"2015","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1074\/jbc.RA120.015327_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.109","article-title":"Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Abeta APP mutation","volume":"2","author":"Kulic","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1074\/jbc.RA120.015327_bib39","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1523\/JNEUROSCI.5167-03.2004","article-title":"Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain","volume":"24","author":"Takahashi","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1074\/jbc.RA120.015327_bib40","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00401-010-0679-9","article-title":"Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease","volume":"119","author":"Gouras","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1074\/jbc.RA120.015327_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016575","article-title":"Peripheral delivery of a CNS targeted, metalo-protease reduces abeta toxicity in a mouse model of Alzheimer's disease","volume":"6","author":"Spencer","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA120.015327_bib42","doi-asserted-by":"crossref","first-page":"17917","DOI":"10.1074\/jbc.M114.557439","article-title":"A\u00a0neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesis","volume":"289","author":"Spencer","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.RA120.015327_bib43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1749-6632.2008.03972.x","article-title":"The role of neuroimmunomodulation in Alzheimer's disease","volume":"1153","author":"Maccioni","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1074\/jbc.RA120.015327_bib44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","article-title":"Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease","volume":"49","author":"Simard","year":"2006","journal-title":"Neuron"},{"key":"10.1074\/jbc.RA120.015327_bib45","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","article-title":"Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease","volume":"23","author":"Yan","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1074\/jbc.RA120.015327_bib46","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1073\/pnas.1524807113","article-title":"High-speed atomic force microscopy reveals structural dynamics of amyloid beta1-42 aggregates","volume":"113","author":"Watanabe-Nakayama","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.RA120.015327_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1021\/jacs.7b10343","article-title":"Pathways of amyloid-beta aggregation depend on oligomer shape","volume":"140","author":"Barz","year":"2018","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1074\/jbc.RA120.015327_bib48","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1523\/JNEUROSCI.1698-16.2016","article-title":"Large soluble oligomers of amyloid beta-protein from Alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate","volume":"37","author":"Yang","year":"2017","journal-title":"J.\u00a0Neurosci."},{"key":"10.1074\/jbc.RA120.015327_bib49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic Abeta oligomer and Alzheimer's disease: An emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1074\/jbc.RA120.015327_bib50","doi-asserted-by":"crossref","first-page":"S567","DOI":"10.3233\/JAD-179941","article-title":"The amyloid-beta oligomer hypothesis: Beginning of the third decade","volume":"64","author":"Cline","year":"2018","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.RA120.015327_bib51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/alzrt203","article-title":"On the subject of rigor in the study of amyloid beta-protein assembly","volume":"5","author":"Teplow","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1074\/jbc.RA120.015327_bib52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fncel.2015.00191","article-title":"Soluble amyloid-beta oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease","volume":"9","author":"Ferreira","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1074\/jbc.RA120.015327_bib53","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","article-title":"The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy","volume":"6","author":"Sengupta","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1074\/jbc.RA120.015327_bib54","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1074\/jbc.RA120.015327_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10561-008-9067-2","article-title":"The sun health research Institute brain donation program: Description and experience, 1987-2007","volume":"9","author":"Beach","year":"2008","journal-title":"Cell Tissue Bank"},{"key":"10.1074\/jbc.RA120.015327_bib56","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/neup.12189","article-title":"Arizona study of aging and neurodegenerative disorders and brain and body donation program","volume":"35","author":"Beach","year":"2015","journal-title":"Neuropathology"},{"key":"10.1074\/jbc.RA120.015327_bib57","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1083\/jcb.200705042","article-title":"Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice","volume":"178","author":"He","year":"2007","journal-title":"J.\u00a0Cell Biol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821000053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821000053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA120.015327","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T16:20:08Z","timestamp":1698510008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925821000053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":57,"alternative-id":["S0021925821000053"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra120.015327","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A conformation-specific antibody against oligomeric \u03b2-amyloid restores neuronal integrity in a mouse model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA120.015327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100241"}}